Scientific Officer: Analytical Chemist
Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.
The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.
The Cancer Research UK Cancer Therapeutics Unit (CTU), within the Division of Cancer Therapeutics, is a multidisciplinary 'bench to bedside' centre, comprising around 160 staff dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer. We are probably the largest academic cancer drug discovery group in the world and, since 2010, 9 drugs discovered by CTU scientists, either alone or in collaboration with a commercial partner, have been studied in our ICR/Royal Marsden Drug Development Unit. Our drug abiraterone has been approved in the US, Canada and Europe for late stage prostate cancer.
We are looking for a new colleague to help our highly productive analytical facility within the Cancer Therapeutics Unit at ICR provide world class expertise in the fields of structural characterisation and physicochemical properties assay of potential new anticancer drugs.
In addition to analytical expertise on medicinal chemistry related projects they will support chemists and biologists by maintaining departmental analytical instrumentation. They will provide training and supervision for communal analytical equipment. They will also aid in the interpretation of results obtained using a variety of spectroscopic techniques and assist in the running of more complex analyses for Cancer Therapeutics.
Candidates must possess a first degree in chemistry or biological sciences with a strong analytical element.
First-hand experience of liquid chromatography and knowledge of mass spectrometry & NMR theory is essential.
Please apply to via the e-recruitment system, available on the ICR website.
This Program is closed to applications.